000 01414 a2200361 4500
005 20250517203817.0
264 0 _c20180910
008 201809s 0 0 eng d
022 _a1791-244X
024 7 _a10.3892/ijmm.2018.3531
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHua, Fu
245 0 0 _aDaidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade.
_h[electronic resource]
260 _bInternational journal of molecular medicine
_cJun 2018
300 _a3485-3492 p.
_bdigital
500 _aPublication Type: Journal Article; Retracted Publication
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Cycle Checkpoints
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIsoflavones
_xpharmacology
650 0 4 _aMAP Kinase Signaling System
_xdrug effects
650 0 4 _aOvarian Neoplasms
650 0 4 _aProto-Oncogene Proteins c-raf
_xmetabolism
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aLi, Chang-Hua
700 1 _aChen, Xiao-Gang
700 1 _aLiu, Xiao-Ping
773 0 _tInternational journal of molecular medicine
_gvol. 41
_gno. 6
_gp. 3485-3492
856 4 0 _uhttps://doi.org/10.3892/ijmm.2018.3531
_zAvailable from publisher's website
999 _c28153234
_d28153234